Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Chad Vickers(Millennium Engineering and Integration (United States)), Peter J. Tummino(Intarcia Therapeutics (United States)), Elizabeth Baronas(BC Platforms (Finland)), Thomas F. Parsons(Millennium Engineering and Integration (United States)), F. Hsieh(VA Palo Alto Health Care System), Michael A. Patane(IIT@MIT), Virendar K. Kaushik(Broad Institute), Susan Acton(Io Therapeutics (United States)), James M. Gavin(Millennium Engineering and Integration (United States)), Jin Tang(BC Platforms (Finland)), Paul Hales(Millennium Engineering and Integration (United States)), Andrew J. Nichols(New Frontier), Kevin Godbout(BC Platforms (Finland))
Cited by 1,424
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
|Nature|2017|878
Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
|Biochemistry|2008|550